News
- Author:
- Liam Davenport
Publish date: July 9, 2020
One combination to avoid is proton pump inhibitors and chemotherapy regimens containing capecitabine.
News
- Author:
- Liam Davenport
Publish date: July 7, 2020
Patients with gastrointestinal cancers should be screened for NTRK fusions to select for treatment with the TRK i...
News
- Author:
- Liam Davenport
Publish date: July 2, 2020
In one study, the team was able to nearly halve the time from diagnosis to initiation of antipsychotic treatment.
News
- Author:
- Liam Davenport
Publish date: June 30, 2020
The results "highlight ACE as a promising peripheral biomarker to identify patients at risk of treatment resistance to antipsychotics," the investi...
News
- Author:
- Liam Davenport
Publish date: June 26, 2020
The highest preference for LAIs was in Europe, at 88%, versus 59.1% in the United States and 70.7% in the rest of the world.
News
- Author:
- Liam Davenport
Publish date: June 23, 2020
Those with COVID-19 do appear to mount a stress response to the infection, and cortisol levels on admission to hospital can help determine the prog...
News
- Author:
- Liam Davenport
Publish date: June 23, 2020
It might be beneficial to identify the specific cause of the psychological discomfort driving cannabis use, such as depression, said Dr. Edoardo Sp...
News
- Author:
- Liam Davenport
Publish date: June 17, 2020
Dose-adjusted chemotherapy can avoid severe toxicities in treating adult Burkitt lymphoma patients.
News
- Author:
- Liam Davenport
Publish date: June 11, 2020
Cisplatin plus radiotherapy is less toxic and produces better outcomes when given weekly rather than once every 3...
News
- Author:
- Liam Davenport
Publish date: June 9, 2020
Receiving imatinib for 3 years rather than 1 year improved overall survival by 50% and recurrence-free survival by 30%.
News
- Author:
- Liam Davenport
Publish date: June 3, 2020
Median overall survival was the same whether patients with metastatic colorectal cancer received encorafenib-cetu...
News
- Author:
- Liam Davenport
Publish date: June 2, 2020
Trastuzumab deruxtecan produced responses in 45% of patients with heavily pretreated HER2-positive colorectal can...
News
- Author:
- Liam Davenport
Publish date: May 14, 2020
Maintenance olaparib improved overall survival, when compared with placebo, in patients with platinum-sensitive, ...
News
- Author:
- Liam Davenport
Publish date: April 23, 2020
Across the two surveys, respondents’ primary concern was anxiety, which was cited in 750 responses.
News
- Author:
- Liam Davenport
Publish date: April 17, 2020
Data suggest obesity is twice as likely to result in hospitalization for COVID-19 and can significantly increase ...
